Chief Executive, Action on Smoking and Health (ASH)
Deborah Arnott is a recognised international expert on tobacco control and the WHO Framework Convention on Tobacco Control, with a particular interest in nicotine regulation and harm reduction. She was a member of the NICE Programme Development Group which developed the guidance on tobacco harm reduction and of the Commission on Human Medicines expert advisory group to the MHRA on nicotine containing products. She also has experience of product regulation under the EU General Product Safety Directive having participated in the development of fire safety requirements for cigarettes.
Deborah has an MBA from Cranfield, is an honorary Associate Professor at the University of Nottingham, and a member of the Royal College of Physicians Tobacco Advisory Group. She was awarded the Alwyn Smith prize in 2007 by the Faculty of Public Health for her outstanding contribution to public health.
Competing Interest: None Stated
Director, Counterfactual Consulting Ltd
Clive Bates has had a diverse career in the public, private and not-for-profit sectors. He started out with the IT company, IBM, then switched career to work in the environment movement. From 1997-2003 he was Director of Action on Smoking and Health (UK), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector and for the United Nations in Sudan. He is now Director of Counterfactual, a consulting and advocacy practice focussed on a pragmatic approach to sustainability and public health.
Professor of History, London School of Hygiene and Tropical Medicine
Virginia Berridge is Professor of History at the London School of Hygiene and Tropical Medicine and founder Director of the Centre for History in Public Health there.
She has written extensively on history and policy issues in relation to illicit drugs, alcohol, smoking, HIV/AIDS and the relation of evidence ( including history) to policy. Her most recent books are : Demons .Our changing attitudes to alcohol, tobacco and drugs (Oxford University Press, 2013)and Public Health. A Very Short Introduction (Oxford University Press ,2016).
Virginia is Senior Editor History for the journal Addiction. She is currently the PI of a Wellcome Trust funded cross national study looking at history evidence and policy in relation to e cigarettes in Australia, the UK and the US.
Research Fellow, London South Bank University's Centre for Addictive Behaviours Research
Dr Sharon Cox is a Trial Manager and Research Fellow at the Centre for Addictive Behaviours Research at London South Bank University. She has over ten years’ experience working in the drug and alcohol field, as both a clinician and a researcher. She has published a number of academic works on both nicotine and alcohol use. She is particularly focused on understanding the disparity between treatment availability and engagement, especially between different communities and by socioeconomic status. Her current research is focused on smoking cessation amongst homeless adults, the impact of e-cigarette health warning labels on perceptions of risk, and an ethnographic exploration of ‘street drinking’ in East London.
Owner & Director, Clarityse Ltd
Owner & Director, Clarityse Ltd. Co-owner & Director, MI Vape Ltd
Mark worked for GSK for 17 years including eight years working on their Smoking Control business, in Global, European and UK marketing / public policy roles; he now also co-owns a vape shop.
Mark helped launch NiQuitin across Europe in 1998; he then managed GSK Consumer Healthcare’s UK Smoking Control business through the period in which NRT was made reimbursable and the NHS Stop Smoking Services emerged. During this period, the prescription NRT grew to be similar in size to the non-prescription market.
Mark now runs his Clarityse consulting business alongside running a vape shop via a franchise in Tooting, London – continuing his passion for helping smokers quit.
Tobacco Control Programme Lead, Publich Health England
Martin is Tobacco Control Programme Lead for Public Health England. He joined PHE in February after 7 years at Action on Smoking and Health. Martin has worked in Public Health since the mid 1980’s when he was involved in HIV prevention work. He is a fellow of the Royal Society of Public Health.
Research Fellow, Onassis Cardiac Surgery Greece, Department of Pharmacology, University of Patras, Greece
Konstantinos E. Farsalinos, M.D., is a research fellow at the Onassis Cardiac Surgery Center in Athens-Greece, at the Department of Pharmacy, University of Patras-Greece and at the National School of Public Health-Greece. He has been conducting laboratory and clinical research on e-cigarettes as a principal investigator since 2011. Examples of his work include the first study on the cytotoxic effects of e-cigarette vapor on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation. He ran a worldwide online survey of almost 20,000 vapers (users of e-cigarettes) identifying patterns of use and experience with e-cigarettes among consumers, published in 2014. He also co-authored the first systematic review on e-cigarette safety, published in 2014. He has analyzed patterns of e-cigarette use based on large European and US population surveys (Eurobarometer, National Youth Tobacco Survey). Additionally, he is performing research work on heated tobacco products. His research findings have been presented in major international scientific congresses and his studies were used in preparing the regulatory framework on e-cigarettes by the European Union. As of late 2018, he has published more than 70 studies and articles in international peer-reviewed scientific journals about smoking, tobacco harm reduction, and e-cigarettes. He was the handling editor and author in a book titled “Analytical assessment of e-cigarettes”, published by Elsevier in 2017.
Competing Interest: For some of the studies, the institution has received funding from e-cigarette companies. None of the researchers received any compensation for participating to the studies.
Professor of Clinical Psychology, Queen Mary University of London
Peter Hajek is Professor of Clinical Psychology and Director of the Tobacco Dependence Research Unit at the Wolfson Institute of Preventive Medicine, Queen Mary University of London. His research is concerned primarily with understanding health behaviours, and developing and evaluating both behavioural and pharmacological treatments for dependent smokers and for people with weight problems. Professor Hajek is a member of a number of expert groups, advisory bodies and editorial boards, and has authored or co-authored over 350 publications.
Vaper, Board Member NNA
Since leaving school ‘a very long time ago’ Sarah Jakes has worked in the shipping industry, the foreign exchange market and now runs her own business in property management.
A smoker of some 35 years Sarah switched to vaping in April 2013, only to find that the choice of this safer alternative for smokers was under threat from excessive and ill founded regulation. Having joined forces with other consumers in the battle against over regulation in the EU parliament Sarah is convinced that a better understanding of e-cigarettes and other harm reduced products among key influencers and decision makers is required if these products are ever to reach their full potential for public health gains.
Founder, E-Cigarette Forum and Vaping.com
Chair, House of Commons Science and Technology Select Committee
Norman Lamb has been the Liberal Democrat MP for North Norfolk since 2001. After serving as a minister in the Department for Business, Innovation and Skills, he was appointed Minister of State for Care and Support at the Department of Health in September 2012 and served in this position until the end of the Coalition Government in May 2015. As Health Minister, Norman worked to reform the care system and led the drive to integrate health and social care, with a greater focus on preventing ill health. He also challenged the NHS to ensure that mental health was treated with the same priority as physical health, including the introduction of access and waiting standards in mental health for the first time. He was the Liberal Democrat Health spokesperson between 2015 and 2017, and was elected Chair of the Science & Technology Select Committee in July 2017.
Senior Researcher, Norwegian Institute of Public Health
Karl E Lund is currently Senior Researcher at the Norwegian Institute of Public Health. He was Research Director at the Norwegian Institute for Alcohol and Drug Research for the period 2006-2018. Dr Lund has been involved in tobacco control work since the mid-1980s, received the Norwegian Medical Association’s Award in preventive medicine in 2000 and has been a member of several expert committees including WHO’s International Agency for Cancer Research (IARC). He is member of the editorial board in four scientific journals, including Nicotine & Tobacco Research. Dr Lund has been an expert witness for the plaintiff in several tort liability lawsuits against the tobacco industry including one brought before the Norwegian Supreme Court. Dr. Lund holds a Ph.D. in Sociology from 1996 and he was formally assessed with qualifications as Professor in 2009.
Principal Toxicologist, Public Health England
Completed his BSc (Hons) in Biochemistry and PhD at University of Surrey then post-docs at Universities of Turin, Okayama and Aberystwyth before taking up a lectureship at University of Leicester. Currently he is a Principal Toxicologist at Centre for Radiation, Chemical and Environmental Hazards, Public Health England providing advice to UK Government Departments and Agencies and conducting research including human biomonitoring, e-cigarettes, mass casualty decontamination and CO poisoning. E-cigarette research is on-going as part of H2020 SmokeFreeBrain project in collaboration with St George’s University of London.
Professor of Tobacco Addiction, UK Centre for Tobacco and Alcohol Studies (UKCTAS), Kings College London
Ann McNeill is Professor of Tobacco Addiction in the National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience. She carried out her PhD at the then Institute of Psychiatry focusing on the development of dependence on smoking. Since that time she has held a variety of academic and public sector posts focusing largely on tobacco control research. Ann has an established international reputation, receiving a World Health Organisation award for contributions to tobacco control in 1998. She has published more than 250 academic papers book chapters, reports and opinion pieces on the subject and her research ranges across prevention, cessation, harm reduction and local, national and international policy. Ann is a Deputy Director of the UK Centre for Tobacco and Alcohol Studies.
Competing Interest: None Stated
Managing Director, ECigIntelligence
The founder and managing director of ECigIntelligence, Tim is a UK-qualified attorney, having worked at the European Commission, BSkyB and Herbert Smith (an international law firm), AOL Europe, as director of public affairs at Betfair (IPO in 2010 valued at £1.5bn), and as a partner in a New York VC-funded start-up in the diamond sector. Tim holds a Postgraduate Diploma in Legal Practice from the University of Law, London and a Masters in Geology from Oxford University.
Director, Tobacco Research & Treatment Center, Massachusetts General Hospital, Boston
Nancy Rigotti, MD, is an internationally known expert in tobacco use, tobacco cessation, and tobacco control public policy. Trained as a general internist, she is Associate Chief of the Division of General Internal Medicine at Massachusetts General Hospital, a Professor of Medicine at Harvard Medical School, and Past President of both the Society of General Internal Medicine and the Society for Research in Nicotine and Tobacco. Dr. Rigotti founded and directs the Tobacco Research and Treatment Center at Massachusetts General Hospital. This program combines a clinical service (MGH Tobacco Treatment Smoking Service) with a multidisciplinary research group whose mission is to develop innovative and effective smoking cessation treatment and tobacco control policy approaches. Her research includes formal evaluations of the effects of tobacco control public policy and clinical and outcomes research studies testing behavioral and pharmacologic smoking cessation treatments. Her current research focuses on developing and testing systems that embed tobacco dependence treatment into the evolving U.S. health care delivery system, with a special interest in using hospitalization as an opportunity to promote tobacco cessation. With colleagues from the Tobacco Research and Treatment Center and DFHCC, Dr. Rigotti is also testing smoking cessation interventions targeting patients with cancer, peripheral vascular disease, parents of children attending pediatric practices, and patients in primary care practices.
Associate Professor, University College London (UCL)
Dr Shahab is a senior lecturer in health psychology at University College London and trained in psychology, epidemiology and neuroscience. He has more than 10 years’ experience in tobacco control with a particular interest in novel behavioural and pharmacological smoking cessation interventions, biomarkers, tobacco product regulation and policy and tobacco use epidemiology.
Conflicts of Interest Statement:
Lion Shahab is a HEFCE funded member of staff at University College London. He has received honoraria for talks, unrestricted research grants and travel expenses to attend meetings and workshops from pharmaceutical companies that makes smoking cessation products, and has acted as paid reviewer for grant awarding bodies and as a paid consultant for health care companies. Other research has been funded by the government, a community-interested company (National Centre for Smoking Cessation) and charitable sources. He has never received personal fees or research funding of any kind from alcohol, electronic cigarette or tobacco companies.
Research Fellow, University of York
I am a Research Fellow in the Sociology Department at the University of York working on health, class and culture, with a special interest in smoking and health inequalities.
I am Principal Investigator on the Cancer Research UK-funded research project ‘Electronic cigarettes, health inequalities and smoking cessation: a community study of take-up and market evolution in two high smoking prevalence areas of the North of England’. The project runs until March 2019 and involves ethnographic fieldwork in the North East and North West.
Specialty Registrar in Public Health, Rochdale Borough Council
Kuiama Thompson is a Senior Public Health Specialty Registrar currently based at Rochdale Borough Council. She has worked in public health in Greater Manchester for over twelve years, leading various programmes of work. She has a keen interest in improving health outcomes and reducing health inequalities amongst the most disadvantaged. Recently she has led the implementation of a smoking cessation pilot in Salford, on behalf of the Greater Manchester Health & Social Care partnership. Over 1,000 free e-cigarettes were provided to support people with their quit attempt. She is currently advising on how e-cigarettes might play a greater role in Greater Manchester smoking cessation services.
Director General, Tobacco Control Directorate, Health Canada
James Van Loon is the Director General of Health Canada’s Tobacco Control Directorate. He has led the development and implementation of Canada’s Tobacco Strategy since 2017.
James has been working in environment and health-related public policy for over 20 years. He has held various leadership positions at both Health Canada and Environment and Climate Change Canada. Most recently, he held the position of Director General of Health Canada’s Consumer Product Safety Directorate. In addition to Tobacco and Consumer Products, he has significant experience in toxic substances management, drinking water protection, and environmental assessment.
James holds a master’s degree in Environmental Studies from York University in Toronto and a bachelor’s degree in Biology from McGill University in Montreal.
International Tobacco Control Consultant
In her three decades in tobacco control, Judith Watt has been an advocate, strategist and mentor at UK, Australian and global levels. Her career has included communications planning, policy development and advocacy, and pioneering work in supporting advocates in low- and middle-income countries.
Judith’s initial experience came in running national campaigns in the UK and Australia in the 1980s and 1990s, where she lay the groundwork for initiatives that are still widely seen as models internationally, including the “Every cigarette is doing you damage” TV campaign that has been adapted for use in over 40 countries.
She played a central role in establishing grants programmes, including the $10m Open Society Foundation programme in Central and Eastern Europe; the first phase of the $40m Bloomberg global programme for The Union; and the £5m international programme of Cancer Research UK.
She is a member of the Board of the Framework Convention Alliance and has served as Secretary and now Treasurer.
Professor of Health Psychology, Dep't of Behavioural Science and Health,UCL
Robert West is Professor of Health Psychology and Director of the Tobacco and Alcohol Research Group, University College London, UK. Professor West is also Editor-in-Chief of the journal Addiction. He is co-author of the English National Smoking Cessation Guidelines that provided the blueprint for the UK-wide network of stop-smoking services that are now an established part of the UK National Health Service. His research includes evaluations of methods of helping smokers to stop and population surveys of smoking and smoking cessation patterns.
I undertake research and consultancy for companies that develop and manufacture smoking cessation medications including licensed nicotine products.
ASH New Zealand
Ben has worked in tobacco control since 2002 when he was the manager of the UK No Smoking Day campaign. For the last decade he has lived in New Zealand, predominantly working on tobacco control advocacy, but also as the political campaign director for the New Zealand coalition government’s Green Party. He currently works as an independent contractor to health NGOs with a focus on NCD and tobacco policy. He has a particular interest in harm reduction and health equity.